Burton BK and Giugliani R. Diagnosing Hunter syndrome in pediatric practice: practical considerations and common pitfalls. Eur J Pediatr 2012; 171(4): 631–9.
Giugliani R, et al. Guidelines for diagnosis and treatment of Hunter Syndrome for clinicians in Latin America. Genet Mol Biol 2014; 37(2): 315–29.
Holt JB, et al. Natural progression of neurological disease in mucopolysaccharidosis type II. Pediatrics 2011; 127(5) :e1258–65.
Kamin W. Diagnosis and management of respiratory involvement in Hunter syndrome. Acta Paediatr Suppl 2008; 97(457): 57–60.
Kampmann C, et al. Prevalence and characterization of cardiac involvement in Hunter syndrome. J Pediatr 2011; 159(2): 327–31.e2.
Keilmann A, et al. Hearing loss in patients with mucopolysaccharidosis II: data from HOS – the Hunter Outcome Survey. J Inherit Metab Dis. 2012; 35(2): 343–53.
Link B, et al. Orthopedic manifestations in patients with mucopolysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome Survey. Orthop Rev (Pavia) 2010; 2(2): e16.
Martin R, et al. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics 2008; 121(2): e377–86.
Mendelsohn NJ, et al. Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey. Genet Med 2010; 12(12): 816–22.
Muenzer J, et al. Multidisciplinary management of Hunter syndrome. Pediatrics 2009; 124(6): e1228–39.
Muenzer J. Overview of the mucopolysaccharidoses. Rheumatology (Oxford) 2011; 50 Suppl 5: v4–12.
Scarpa M, et al. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet J Rare Dis 2011; 6: 72.
Wraith JE, et al. Initial report from the Hunter Outcome Survey. Genet Med 2008; 10(7): 508–16.

In this section:

MPS Day 2017

Close or ESC